SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-021575
Filing Date
2018-08-14
Accepted
2018-08-14 07:36:19
Documents
71
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q itrm-10q_20180630.htm 10-Q 1974445
2 EX-31.1 itrm-ex311_9.htm EX-31.1 19057
3 EX-31.2 itrm-ex312_8.htm EX-31.2 18933
4 EX-32.1 itrm-ex321_7.htm EX-32.1 10274
5 EX-32.2 itrm-ex322_6.htm EX-32.2 10291
  Complete submission text file 0001564590-18-021575.txt   6792096

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT itrm-20180630.xml EX-101.INS 1476288
7 XBRL TAXONOMY EXTENSION SCHEMA itrm-20180630.xsd EX-101.SCH 48908
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itrm-20180630_cal.xml EX-101.CAL 48864
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itrm-20180630_def.xml EX-101.DEF 180568
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE itrm-20180630_lab.xml EX-101.LAB 360341
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itrm-20180630_pre.xml EX-101.PRE 285169
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38503 | Film No.: 181014273
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1